 | • レポートコード：GIR-105X13764 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、プロマクタのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。プロマクタの種類別市場規模（25mg、50mg、75mg）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・プロマクタの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：25mg、50mg、75mg ・用途別分析2016年-2026年：病院、ドラッグストア、その他 ・プロマクタの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・プロマクタのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・プロマクタのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・プロマクタの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・プロマクタの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Promacta market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Promacta size is estimated to be xx million in 2020 from USD XX million in 2019, with a change of XX% between 2019 and 2020. The global Promacta market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
Promacta market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
25mg
50mg
75mg
Market segment by Application can be divided into
Hospital
Drugs Stores
Other
The key market players for global Promacta market are listed below:
Novartis Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Promacta Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Promacta Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 25mg
1.2.3 50mg
1.2.4 75mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Promacta Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Global Promacta Market Size & Forecast
1.4.1 Global Promacta Sales in Value (2016-2026))
1.4.2 Global Promacta Sales in Volume (2016-2026)
1.4.3 Global Promacta Price by Type (2016-2026) & (USD/MT)
1.5 Global Promacta Production Capacity Analysis
1.5.1 Global Promacta Total Production Capacity (2016-2026)
1.5.2 Global Promacta Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Promacta Market Drivers
1.6.2 Promacta Market Restraints
1.6.3 Promacta Trends Analysis
2 Manufacturers Profiles
2.1 Novartis Pharmaceuticals
2.1.1 Novartis Pharmaceuticals Details
2.1.2 Novartis Pharmaceuticals Major Business
2.1.3 Novartis Pharmaceuticals Promacta Product and Services
2.1.4 Novartis Pharmaceuticals Promacta Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Promacta Sales by Manufacturer
3.1 Global Promacta Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Promacta Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Promacta
3.4 Market Concentration Rate
3.4.1 Top 3 Promacta Manufacturer Market Share
3.4.2 Top 6 Promacta Manufacturer Market Share
3.5 Global Promacta Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Promacta Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Promacta Market Size by Region
4.1.1 Global Promacta Sales in Volume by Region (2016-2026)
4.1.2 Global Promacta Revenue by Region (2016-2026)
4.2 North America Promacta Revenue (2016-2026)
4.3 Europe Promacta Revenue (2016-2026)
4.4 Asia-Pacific Promacta Revenue (2016-2026)
4.5 South America Promacta Revenue (2016-2026)
4.6 Middle East and Africa Promacta Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Promacta Sales in Volume by Type (2016-2026)
5.2 Global Promacta Revenue by Type (2016-2026)
5.3 Global Promacta Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Promacta Sales in Volume by Application (2016-2026)
6.2 Global Promacta Revenue by Application (2016-2026)
6.3 Global Promacta Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Promacta Sales by Type (2016-2026)
7.2 North America Promacta Sales by Application (2016-2026)
7.3 North America Promacta Market Size by Country
7.3.1 North America Promacta Sales in Volume by Country (2016-2026)
7.3.2 North America Promacta Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Promacta Sales by Type (2016-2026)
8.2 Europe Promacta Sales by Application (2016-2026)
8.3 Europe Promacta Market Size by Country
8.3.1 Europe Promacta Sales in Volume by Country (2016-2026)
8.3.2 Europe Promacta Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Promacta Sales by Type (2016-2026)
9.2 Asia-Pacific Promacta Sales by Application (2016-2026)
9.3 Asia-Pacific Promacta Market Size by Region
9.3.1 Asia-Pacific Promacta Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Promacta Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Promacta Sales by Type (2016-2026)
10.2 South America Promacta Sales by Application (2016-2026)
10.3 South America Promacta Market Size by Country
10.3.1 South America Promacta Sales in Volume by Country (2016-2026)
10.3.2 South America Promacta Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Promacta Sales by Type (2016-2026)
11.2 Middle East & Africa Promacta Sales by Application (2016-2026)
11.3 Middle East & Africa Promacta Market Size by Country
11.3.1 Middle East & Africa Promacta Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Promacta Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Promacta Typical Distributors
12.3 Promacta Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Promacta Revenue by Type, (USD Million), 2021-2026
Table 2. Global Promacta Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Pharmaceuticals Major Business
Table 5. Novartis Pharmaceuticals Promacta Product and Services
Table 6. Novartis Pharmaceuticals Promacta Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Promacta Sales by Manufacturer (2019-2021e) & (K MT)
Table 8. Global Promacta Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Promacta, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Promacta Production Capacity by Company, (K MT): 2020 VS 2021
Table 11. Head Office and Promacta Production Site of Key Manufacturer
Table 12. Global Promacta Sales by Region (2016-2021e) & (K MT)
Table 13. Global Promacta Sales by Region (2021-2026) & (K MT)
Table 14. Global Promacta Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Promacta Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Promacta Sales by Type (2016-2021e) & (K MT)
Table 17. Global Promacta Sales by Type (2021-2026) & (K MT)
Table 18. Global Promacta Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Promacta Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Promacta Price by Type (2016-2021e) & (USD/MT)
Table 21. Global Promacta Price by Type (2021-2026) & (USD/MT)
Table 22. Global Promacta Sales by Application (2016-2021e) & (K MT)
Table 23. Global Promacta Sales by Application (2021-2026) & (K MT)
Table 24. Global Promacta Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Promacta Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Promacta Price by Application (2016-2021e) & (USD/MT)
Table 27. Global Promacta Price by Application (2021-2026) & (USD/MT)
Table 28. North America Promacta Sales by Country (2016-2021e) & (K MT)
Table 29. North America Promacta Sales by Country (2021-2026) & (K MT)
Table 30. North America Promacta Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Promacta Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Promacta Sales by Type (2016-2021e) & (K MT)
Table 33. North America Promacta Sales by Type (2021-2026) & (K MT)
Table 34. North America Promacta Sales by Application (2016-2021e) & (K MT)
Table 35. North America Promacta Sales by Application (2021-2026) & (K MT)
Table 36. Europe Promacta Sales by Country (2016-2021e) & (K MT)
Table 37. Europe Promacta Sales by Country (2021-2026) & (K MT)
Table 38. Europe Promacta Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Promacta Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Promacta Sales by Type (2016-2021e) & (K MT)
Table 41. Europe Promacta Sales by Type (2021-2026) & (K MT)
Table 42. Europe Promacta Sales by Application (2016-2021e) & (K MT)
Table 43. Europe Promacta Sales by Application (2021-2026) & (K MT)
Table 44. Asia-Pacific Promacta Sales by Region (2016-2021e) & (K MT)
Table 45. Asia-Pacific Promacta Sales by Region (2021-2026) & (K MT)
Table 46. Asia-Pacific Promacta Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Promacta Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Promacta Sales by Type (2016-2021e) & (K MT)
Table 49. Asia-Pacific Promacta Sales by Type (2021-2026) & (K MT)
Table 50. Asia-Pacific Promacta Sales by Application (2016-2021e) & (K MT)
Table 51. Asia-Pacific Promacta Sales by Application (2021-2026) & (K MT)
Table 52. South America Promacta Sales by Country (2016-2021e) & (K MT)
Table 53. South America Promacta Sales by Country (2021-2026) & (K MT)
Table 54. South America Promacta Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Promacta Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Promacta Sales by Type (2016-2021e) & (K MT)
Table 57. South America Promacta Sales by Type (2021-2026) & (K MT)
Table 58. South America Promacta Sales by Application (2016-2021e) & (K MT)
Table 59. South America Promacta Sales by Application (2021-2026) & (K MT)
Table 60. Middle East & Africa Promacta Sales by Country (2016-2021e) & (K MT)
Table 61. Middle East & Africa Promacta Sales by Country (2021-2026) & (K MT)
Table 62. Middle East & Africa Promacta Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Promacta Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Promacta Sales by Type (2016-2021e) & (K MT)
Table 65. Middle East & Africa Promacta Sales by Type (2021-2026) & (K MT)
Table 66. Middle East & Africa Promacta Sales by Application (2016-2021e) & (K MT)
Table 67. Middle East & Africa Promacta Sales by Application (2021-2026) & (K MT)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Promacta Typical Distributors
Table 71. Promacta Typical Customers
List of Figures
Figure 1. Promacta Picture
Figure 2. Global Promacta Sales Market Share by Type in 2020
Figure 3. 25mg
Figure 4. 50mg
Figure 5. 75mg
Figure 6. Global Promacta Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Drugs Stores
Figure 9. Other
Figure 10. Global Promacta Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Promacta Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Promacta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Promacta Sales (2016-2026) & (K MT)
Figure 32. Global Promacta Production Capacity (2016-2026) & (K MT)
Figure 33. Global Promacta Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Promacta Market Drivers
Figure 35. Promacta Market Restraints
Figure 36. Promacta Market Trends
Figure 37. Global Promacta Sales Market Share by Manufacturer in 2020
Figure 38. Global Promacta Revenue Market Share by Manufacturer in 2020
Figure 39. Promacta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Promacta Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Promacta Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Promacta Sales Market Share by Region (2016-2026)
Figure 43. Global Promacta Revenue Market Share by Region (2016-2026)
Figure 44. North America Promacta Revenue (2016-2026) & (USD Million)
Figure 45. Europe Promacta Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Promacta Revenue (2016-2026) & (USD Million)
Figure 47. South America Promacta Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Promacta Revenue (2016-2026) & (USD Million)
Figure 49. Global Promacta Sales Market Share by Type (2016-2026)
Figure 50. Global Promacta Revenue Market Share by Type (2016-2026)
Figure 51. Global Promacta Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Promacta Sales Market Share by Application (2016-2026)
Figure 53. Global Promacta Revenue Market Share by Application (2016-2026)
Figure 54. Global Promacta Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Promacta Sales Market Share by Country (2016-2026)
Figure 56. North America Promacta Revenue Market Share by Country (2016-2026)
Figure 57. North America Promacta Sales Market Share by Type (2016-2026)
Figure 58. North America Promacta Sales Market Share by Application (2016-2026)
Figure 59. Europe Promacta Sales Market Share by Country (2016-2026)
Figure 60. Europe Promacta Revenue Market Share by Country (2016-2026)
Figure 61. Europe Promacta Sales Market Share by Type (2016-2026)
Figure 62. Europe Promacta Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Promacta Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Promacta Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Promacta Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Promacta Sales Market Share by Application (2016-2026)
Figure 67. South America Promacta Sales Market Share by Country (2016-2026)
Figure 68. South America Promacta Revenue Market Share by Country (2016-2026)
Figure 69. South America Promacta Sales Market Share by Type (2016-2026)
Figure 70. South America Promacta Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Promacta Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Promacta Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Promacta Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Promacta Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
Enasidenib薬の世界市場2018-2025 Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic testIn 2018, the global Enasidenib Drugs market size was xx million US$ and is for…- 世界のエルトロンボパグ錠市場 2021：企業別、地域別、種類・用途別 The Eltrombopag Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- ダサチニブ薬の世界市場2018-2025 Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).In 2018, the global Dasatinib Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at …
- 院内肺炎（HAP）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects …
- タイサブリ薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…